Markers of increased risk for failure of adjuvant therapies
- 31 December 2003
- journal article
- Published by Elsevier in The Breast
- Vol. 12 (6), 543-549
- https://doi.org/10.1016/s0960-9776(03)00164-4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 yearsThe Lancet, 2000
- Prognostic variables in node-negative and node-positive breast cancer - editorialBreast Cancer Research and Treatment, 1998
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Breast Cancer Prognostic Factors: Evaluation GuidelinesJNCI Journal of the National Cancer Institute, 1991
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- Cathepsin D and Prognosis in Breast CancerNew England Journal of Medicine, 1990
- Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary reportCancer, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Progesterone Receptors as a Prognostic Factor in Stage II Breast CancerNew England Journal of Medicine, 1983